Now here’s a REALLY unsurprising piece of news!

A new report in the journal JAMA Oncology is said to have detailed “the psychological damage” that a cancer diagnosis “often leaves in its wake for patients.” … READ MORE …

Is stress killing men with localized prostate cancer (at least in Sweden)?

An article just published on line in the Scandinavian Journal of Urology is entitled, “The roles of stress and social support in prostate cancer mortality.” … READ MORE …

Does treatment for prostate cancer lead to PTSD (for at least some men)?

The following two statements appear on the web site of the Mayo Clinic under the definition of post-traumatic stress disorder: … READ MORE …

Coping skills, emotional trauma, and living with prostate cancer

The authors of a newly published paper on stress management and coping skills among men on active surveillance as a first-line management strategy for prostate cancer begin the abstract of their paper with the following sentence: … READ MORE …

No association between stress at work and prostate, other cancers

In another article in the British Medical Journal this week, the authors conclude that “work related stress, measured and defined as job strain, at baseline is unlikely to be an important risk factor for colorectal, lung, breast, or prostate cancers” (at least in a large database of Europeans). … READ MORE …

Could SRY or an SRY-like gene be at the root of risk for prostate cancer?

A new paper just published in BioEssays puts forward the hypothesis that a gene known as the SRY gene, which directs development of “maleness,” may have specific impact on behavioral and on clinical aspects of being male (e.g., aggressiveness; the so-called “flight or fight” response to stress; even some male-based neurological disorders like Parkinson’s disease). … READ MORE …

Duloxetine in treatment of mild to moderate post-surgical incontinence

Let us be clear up front … Duloxetine (Cymbalta®) has not been approved anywhere in the world that we are aware of as a treatment for post-surgical incontinence in men treated for prostate cancer, and there has never been a large, randomized, double-blind Phase III trial to try to demonstrate such activity. … READ MORE …